DPIIT recognised startup Government of India
Startup India
Toxiven Biotech Private Limited - life sciences in Pollachi, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹1.17 Cr
▼ 33% YoY
Net profit · FY 2026
₹30.02 Lakh
Net margin 25.6%
EBITDA · FY 2026
₹58.42 Lakh
EBITDA margin 49.8%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹14.43 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
11
Provident fund records
Directors on board
4
As per MCA filings
About Toxiven Biotech Private Limited
Data last updated:
Toxiven Biotech Private Limited is a private limited company based in Pollachi, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 28 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U24304TZ2019PTC031781. Its GSTIN is 33AAHCT2033L1ZF (Tamil Nadu).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹14.43 Lakh. It is led by directors including Arumugam Sundhararajan and Harry Fonseca Williams.
Its last annual general meeting (AGM) was held on 16 July 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Pollachi, Tamil Nadu.
As per the financials filed for FY 2026, the company reported a revenue of ₹1.17 Cr, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹30.02 Lakh (net margin 25.6%) and EBITDA of ₹58.42 Lakh (EBITDA margin 49.8%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years and 34% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Toxiven.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website toxiven.com.
Company details
CIN U24304TZ2019PTC031781
Registration Number 031781
Incorporation Date 28 February 2019
ROC Coimbatore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Key People
Arumugam Sundhararajan Director Harry Fonseca Williams Director Mohanraj Vaiyapuri Director Recognitions & Rankings of Toxiven Biotech
Contact details
Toxiven Biotech Private Limited's registered office is in Pollachi, Tamil Nadu. Its website is toxiven.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSf No. 22/2A Near Coir Mills, Sangarayapuram, Pollachi, Tamil Nadu, India – 642109
- IndustryLife Sciences, Biotechnology
To see the full contact details of Toxiven Biotech Private Limited, buy the company report.
Comprehensive company report
Toxiven Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Toxiven Biotech operates one associated brand: Toxiven. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pioneering reliable tools for snakebite venom detection and treatment worldwide. | toxiven.com |
Business activity
The main business activity of Toxiven Biotech is professional, scientific and technical activities. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 72 | Scientific research and development |
To see the full business activity and turnover split of Toxiven Biotech Private Limited, buy the company report.
Financials of Toxiven Biotech Private Limited
FY 2026 filings availableToxiven Biotech Private Limited reported revenue of ₹1.17 Cr (down 33% YoY) for FY 2026.
Revenue · FY 2026
₹1.17 Cr ▼ 33%
Net profit · FY 2026
₹30.02 Lakh margin 25.6%
EBITDA · FY 2026
₹58.42 Lakh margin 49.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 33%
3 years · compounded
▲ 49%
5 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▼ 75%
Revenue fell 33% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 34%. EBITDA fell 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.17 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹58.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 49.8% | ||||
| Net Profit Margin | 25.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Toxiven Biotech Private Limited, buy the company report.
Board of directors of Toxiven Biotech Private Limited
Toxiven Biotech has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arumugam Sundhararajan | Director | 22 Nov 2023 | 2 Years 11 Months | Current |
| Harry Fonseca Williams | Director | 20 Mar 2019 | 7 Years 7 Months | Current |
| Mohanraj Vaiyapuri | Director | 25 Nov 2024 | 1 Years 11 Months | Current |
| Padmini Ramachandran | Director | 25 Nov 2024 | 1 Years 11 Months | Current |
Auditor
Toxiven Biotech Private Limited is audited by I P R S & COMPANY for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| I P R S & COMPANY | FY 2026 | 224521 |
Shareholding
The shareholding of Toxiven Biotech Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Toxiven Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Toxiven Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Toxiven Biotech Private Limited has 1 MSME Form 1 return on record for the period ending Sep 2023, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Invitro Sciences |
To see the full MSME payment records of Toxiven Biotech Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Toxiven Biotech Private Limited has a workforce of 11 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
11
Active EPFO establishments
1
Employee growth
-15.4%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 11 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Toxiven Biotech Private Limited, buy the company report.
GST
Toxiven Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCT2033L1ZF | Tamil Nadu | Active | 27 Mar 2019 |
To see the full GST registrations and return filing status of Toxiven Biotech Private Limited, buy the company report.
Recent activity
Toxiven Biotech Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Mohanraj Vaiyapuri was appointed as Director on 25 Nov 2024.
AGM
Toxiven Biotech Private Limited last Annual general meeting of members was held on 16 Jul 2026 as per latest MCA records.
Filing
Toxiven Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Coimbatore.
Appointed
Mohanraj Vaiyapuri was appointed as Director.
Appointed
Padmini Ramachandran was appointed as Director.
Appointed
Arumugam Sundhararajan was appointed as Director.
Ceased
Anitha ceased to be Director.
Ceased
Rajendran ceased to be Director.
Appointed
Harry Fonseca Williams was appointed as Director.
Incorporation
28 Feb 2019
Toxiven Biotech Private Limited was registered on 28 Feb 2019 with Roc Coimbatore & aged 7 years 8 months as per MCA records.
Frequently asked questions
Toxiven Biotech is an active private limited company based in Pollachi, Tamil Nadu, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 28 February 2019 (7+ years old) and is registered under CIN U24304TZ2019PTC031781.
Toxiven Biotech has 4 current directors:
- Arumugam Sundhararajan - Director
- Harry Fonseca Williams - Director
- Mohanraj Vaiyapuri - Director
- Padmini Ramachandran - Director
The latest financial statements of Toxiven Biotech on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 16 July 2026. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Toxiven Biotech is 33AAHCT2033L1ZF, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Toxiven Biotech is U24304TZ2019PTC031781. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Toxiven Biotech was incorporated on 28 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Coimbatore.
Mohanraj Vaiyapuri was appointed as Director on 25 Nov 2024. Padmini Ramachandran was appointed as Director on 25 Nov 2024. Arumugam Sundhararajan was appointed as Director on 22 Nov 2023. Toxiven Biotech has 6 board changes on record in total.
Yes, Toxiven Biotech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Toxiven Biotech has 1 MSME Form 1 return on record for the period ending Sep 2023, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 09 Nov 2023.
Toxiven Biotech can be reached through the website toxiven.com. Its registered office is in Pollachi, Tamil Nadu, India.
The registered office of Toxiven Biotech is at Sf No. 222A Near Coir Mills, Sangarayapuram, Pollachi, Tamil Nadu, India – 642109.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages